THERINI BIO — 2350474
Application number
2350474
International Registration Number
1810339
Type(s)
Standard Characters
Category
Trademark
CIPO Status
SEARCHED
TM5 status
LIVE/APPLICATION/
Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
Filed
2024-07-01
International Registration
2024-07-01
Applicant
Therini Bio, Inc.
2108 N St., Suite 4963
Sacramento CA 95816
UNITED STATES OF AMERICA
Agent
SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2
Documents
Index headings
- THERINI BIO
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical and therapeutic preparations for the treatment of vascular, inflammatory, and neurological diseases and disorders, namely, Alzheimer's disease, dementia, Parkinson's disease, Huntington's disease, multiple sclerosis, cerebrovascular accident (stroke), myasthenia gravis, epilepsy, cerebral palsy, brain injury, spinal cord injury, seizure disorders, tumors, cancer, diabetes, arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases and injuries, inflammatory pelvic diseases, inflammatory muscle diseases and disorders, age related macular degeneration, diabetic retinopathy, proliferative vitreoretinopathy, diabetic macular edema, glaucoma and COVID-19.
Claims
- Priority Filing Date: January 19, 2024, Country or Office: UNITED STATES OF AMERICA, Application No. 98366670 in association with the same kind of goods
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2024-07-01 | Registration | |
| International Registration | 2024-07-01 | 2034-07-01 | |
| Created | 2024-09-18 | ||
| Formalized | 2024-09-18 | ||
| Designation Notification - Madrid Protocol | 2024-09-19 | 2026-03-19 | |
| Notification of Possible Opposition Sent | 2025-07-21 | ||
| Search Recorded | 2025-09-25 | ||
| Examiner's First Report | 2025-09-25 | 2026-03-25 | |
| Total Provisional Refusal | 2025-09-25 | 2026-03-25 | |
| Agent Changed | 2026-01-13 | From/De: To/A: 2502 | |
| Agent Changed | 2026-04-21 | Transferred From: 2502 To: 59 |